Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



Amgen Inc.: Is Wall Street Bullish or Bearish on Amgen Stock?

November 15, 2024
In recent weeks, there has been much debate on Wall Street about the future of Amgen Inc. (NASDAQ:AMGN) stock. Analysts have been closely watching the company's performance and weighing in on whether investors should be bullish or bearish. While some experts believe that Amgen's weak profit is a cause for concern, others argue that there are broader issues at play.

According to a report by Simply Wall St News, Amgen's problems go beyond just weak profit. The company has been facing difficulties in its obesity candidate, which has raised concerns about bone density. However, Amgen appears to be unfazed by these concerns and continues to push forward with its research and development efforts.

One notable investor, Consolidated Planning Corp, has shown faith in Amgen's future by purchasing an additional 1842 shares of the company. Consolidated Planning Corp, which already holds a sizable stake in Amgen, clearly believes that the company's stock has room to grow.

While there is much uncertainty surrounding Amgen's stock, it is important for investors to seek professional guidance. Stocks Prognosis, a team of experienced professionals, offers expert advice on the forecasted movement of Amgen's stock. For investors looking to make informed decisions, Stocks Prognosis provides valuable insights and recommendations.

Investing in the stock market can be a risky endeavor, but with the right knowledge and guidance, it can also be highly rewarding. As the future of Amgen Inc. remains uncertain, it is recommended to consult professionals like Stocks Prognosis to gain insights and make informed investment decisions.
If you want to leave a comment, then you need Login or Register





Other data for AMGN

Related data

AMGNApril 22, 2025Amgen Inc. AMGN: Among the Innovative Healthcare Stocks to Watch in 2025  ~2 min.

Amgen Inc., a leading biotechnology company, is currently one of the most promising stocks in the healthcare sector....

AMGNMarch 20, 2025Hedge Funds Recommend Amgen Inc. AMGN as the Best Pharma Stock to Buy  ~1 min.

According to recent reports, hedge funds are strongly recommending Amgen Inc. (AMGN) as the best pharma stock to buy....

AMGNMarch 19, 2025Amgen Inc. AMGN: Cutting-Edge Biotech Company Dominates Stock Market  ~2 min.

Amgen Inc. (AMGN), renowned for its groundbreaking innovations in biotechnology, continues to make headlines as a leading player in the stock market....

AMGNMarch 17, 2025Amgen Inc. Continues to Impress Hedge Funds with Strong Performance  ~2 min.

Amgen Inc. (NASDAQ:AMGN) has emerged as the top choice for hedge funds looking to invest in the pharmaceutical sector....

AMGNMarch 16, 2025Amgen Inc. AMGN: Discover Why it's Among the Top Pharma Stocks to Buy  ~2 min.

Amgen Inc., a leading biotechnology company, has been gaining attention in the investment community due to its outstanding performance in the pharmaceutical sector....

AMGNMarch 7, 2025AMGEN INC. Hits Price Target Forecast with 19.78% Profit, as Predicted by QuantWave  ~2 min.

AMGEN INC. (AMGN) recently achieved the price target forecast set by QuantWave, resulting in a profit of 19.78% for investors who followed the prediction....

AMGNFebruary 27, 2025Amgen Inc. AMGN: A Promising Investment Opportunity in the Pharmaceutical Industry  ~2 min.

Amgen Inc. (AMGN), a leading biotechnology company, is regarded as one of the best investment options in the pharmaceutical sector, according to analysts at Yahoo Finance....

AMGNFebruary 26, 2025Amgen Inc. AMGN: Among the Cheap Pharmaceutical Stocks to Buy According to Analysts  ~1 min.

Analysts have identified Amgen Inc. (NASDAQ:AMGN) as one of the cheap pharmaceutical stocks to buy....

AMGNFebruary 20, 2025Amgen Inc. AMGN Reports Strong Earnings Amidst Growing Bull Case Theory  ~2 min.

Amgen Inc. (AMGN), a leading biotechnology company, has recently reported strong earnings, surpassing market expectations....

AMGNFebruary 14, 2025Amgen Inc. AMGN: Absurd That This Stock Sells for 14x Earnings  ~2 min.

Amgen Inc. (NASDAQ: AMGN) has been making waves in the pharmaceutical industry with its breakthrough drugs and innovative research....

BBYJanuary 1, 2025Best Buy Faces Uncertain Future with Potential Investment Risks  ~2 min.

Investors who bought shares in Best Buy three years ago are facing losses as the company's stock price has dropped significantly....

DVNDecember 24, 2024Devon Energy Corp. (DVN) Stock Hits 52-Week Low as Market Shifts  ~2 min.

Despite receiving an average recommendation of moderate buy from multiple brokerages, Devon Energy Corporation (DVN) has been underperforming in the energy sector....

AMGNNovember 10, 2024Consolidated Planning Corp Buys 1842 Shares of Amgen Inc. NASDAQ:AMGN  ~2 min.

Consolidated Planning Corp, a prominent investment firm, has recently acquired 1842 shares of the pharmaceutical giant Amgen Inc. NASDAQ:AMGN....

ATOFebruary 3, 2025Pinning Down Atmos Energy Corporations NYSE:ATO PE Is Difficult Right Now  ~1 min.

Atmos Energy Corporation, a leading natural gas distribution company, is facing difficulties in determining its price-to-earnings ratio (PE) at the moment....

BIIBJanuary 7, 2025Biogen Inc. Struggles with Transition Challenges as Analysts Slash Price Targets  ~2 min.

Biogen Inc., a leading biotechnology company, is facing significant challenges in its transition phase....